Additional file 1 of Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program

Nicholls, Stephen J.; Tofé, Santiago; le Roux, Carel W.; D’Alessio, David A.; Wiese, Russell J.; Pavo, Imre; Brown, Katelyn; Weerakkody, Govinda J.; Zeytinoglu, Meltem; Romera, Irene C.

doi:10.6084/m9.figshare.25201920.v1

12933_2024_2147_MOESM1_ESM.docx (142.55 kB)

Additional file 1 of Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program

journal contribution

posted on 2024-02-11, 04:40 authored by Stephen J. Nicholls, Santiago Tofé, Carel W. le Roux, David A. D’Alessio, Russell J. Wiese, Imre Pavo, Katelyn Brown, Govinda J. Weerakkody, Meltem Zeytinoglu, Irene C. Romera

Additional file 1.

Funding

Eli Lilly and Cmpany

History

Usage metrics

Keywords

Metabolic syndrome Type 2 diabetes Tirzepatide Incretin

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1 of Reduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program

Funding

Eli Lilly and Cmpany

History

Usage metrics

Categories

Keywords

Licence

Exports